The Enterprise Value as of December 2025 (TTM) for Champions Oncology, Inc. (CSBR) is 79.51M

According to Champions Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 79.51M. This represents a change of -18.07% compared to the average of 97.05M of the last 4 quarters.

Champions Oncology, Inc. (CSBR) Historical Enterprise Value (quarterly & annually)

How has CSBR Enterprise Value performed in the past?

The mean historical Enterprise Value of Champions Oncology, Inc. over the last ten years is 76.58M. The current 79.51M Enterprise Value has changed 10.28% with respect to the historical average. Over the past ten years (40 quarters), CSBR's Enterprise Value was at its highest in in the January 2025 quarter at 153.80M. The Enterprise Value was at its lowest in in the October 2016 quarter at 13.05M.

Champions Oncology, Inc. (CSBR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Champions Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Champions Oncology, Inc. (CSBR) Average Enterprise Value

How has CSBR Enterprise Value performed in the past?

The current Enterprise Value of Champions Oncology, Inc. (CSBR) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Champions Oncology, Inc. (CSBR) Enterprise Value vs. Peers

How is CSBR’s Enterprise Value compared to its peers?

Champions Oncology, Inc.’s Enterprise Value is less than Atara Biotherapeutics, Inc. (100.89M), greater than Sutro Biopharma, Inc. (31.59M), greater than InflaRx N.V. (51.54M), greater than ImageneBio Inc (23.20M), greater than Kalaris Therapeutics Inc (69.88M), less than Shattuck Labs, Inc. (101.48M), greater than Artiva Biotherapeutics, Inc. (78.84M), less than Connect Biopharma Holdings Limited (102.22M), less than Oramed Pharmaceuticals Inc. (98.45M), less than Metagenomi, Inc. Common Stock (83.35M),

Build a custom stock screener for Champions Oncology, Inc. (CSBR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Champions Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Champions Oncology, Inc. (CSBR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Champions Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.